Jinhe Biotechnology: Net profit of 138 million yuan in the first half of the year, a year-on-year increase of 51.52%.

On the evening of July 30th, Jinhe Biology disclosed its semi-annual report, with the company achieving operating income of 1.39 billion yuan in the first half of 2025, a year-on-year increase of 30.45%; net profit attributable to shareholders was 138 million yuan, a year-on-year increase of 51.52%; and basic earnings per share were 0.18 yuan. During the reporting period, the positive trend in the downstream pig farming industry did not change, driving improvement in demand for upstream animal health products. However, the competition in the animal health industry market remained intense. Faced with the current development situation in the animal health industry, during the reporting period, the company focused on its business goals, placing strategic emphasis on its product structure layout, fully utilizing its competitive advantages in products, continuously innovating in research and development, strengthening lean management internally, and focusing on the market externally, resulting in substantial growth in business performance.